(Q38365624)

English

Atherosclerotic vascular disease in the autoimmune rheumatologic patient

scientific article published on April 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

2 September 2017

1 reference

Europe PubMed Central

Atherosclerotic vascular disease in the autoimmune rheumatologic patient (English)

1 reference

Europe PubMed Central

2 September 2017

atherosclerosis

1 reference

based on heuristic

inferred from title

author name string

Rekha Mankad

1

1 reference

Europe PubMed Central

2 September 2017

publication date

1 April 2015

1 reference

Europe PubMed Central

2 September 2017

Current Atherosclerosis Reports

1 reference

Europe PubMed Central

2 September 2017

17

1 reference

Europe PubMed Central

2 September 2017

4

1 reference

Europe PubMed Central

2 September 2017

497

1 reference

Europe PubMed Central

2 September 2017

https://scigraph.springernature.com/pub.10.1007/s11883-015-0497-6

0 references

Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the american heart association.

1 reference

https://api.crossref.org/works/10.1007%2FS11883-015-0497-6

21 January 2018

The bimodal mortality pattern of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1007%2FS11883-015-0497-6

21 January 2018

Accelerated atherosclerosis in autoimmune rheumatic diseases

1 reference

https://api.crossref.org/works/10.1007%2FS11883-015-0497-6

21 January 2018

Increased risk of acute myocardial infarction in systemic sclerosis: a nationwide population-based study.

1 reference

https://api.crossref.org/works/10.1007%2FS11883-015-0497-6

21 January 2018

Chronic inflammatory diseases and cardiovascular risk: a systematic review

1 reference

https://api.crossref.org/works/10.1007%2FS11883-015-0497-6

21 January 2018

Inflammation in atherosclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS11883-015-0497-6

21 January 2018

Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association

1 reference

https://api.crossref.org/works/10.1007%2FS11883-015-0497-6

21 January 2018

The discovery of cellular immunity in the atherosclerotic plaque

1 reference

https://api.crossref.org/works/10.1007%2FS11883-015-0497-6

21 January 2018

Cytokines in atherosclerosis: pathogenic and regulatory pathways

1 reference

https://api.crossref.org/works/10.1007%2FS11883-015-0497-6

21 January 2018

Innate and adaptive immunity in the pathogenesis of atherosclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS11883-015-0497-6

21 January 2018

Innate and acquired immunity in atherogenesis

1 reference

https://api.crossref.org/works/10.1007%2FS11883-015-0497-6

21 January 2018

Accelerated atherosclerosis, immune response and autoimmune rheumatic diseases

1 reference

https://api.crossref.org/works/10.1007%2FS11883-015-0497-6

21 January 2018

How early is the atherosclerotic risk in rheumatoid arthritis?

1 reference

https://api.crossref.org/works/10.1007%2FS11883-015-0497-6

21 January 2018

Mortality in early inflammatory polyarthritis: cardiovascular mortality is increased in seropositive patients.

1 reference

https://api.crossref.org/works/10.1007%2FS11883-015-0497-6

21 January 2018

The inextricable link between atherosclerosis and prototypical inflammatory diseases rheumatoid arthritis and systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1007%2FS11883-015-0497-6

21 January 2018

Inflammation, atherosclerosis, and coronary artery disease

1 reference

https://api.crossref.org/works/10.1007%2FS11883-015-0497-6

21 January 2018

CD4+CD28- T lymphocytes contribute to early atherosclerotic damage in rheumatoid arthritis patients

1 reference

https://api.crossref.org/works/10.1007%2FS11883-015-0497-6

21 January 2018

Inflammatory and autoimmune mechanisms in the induction of atherosclerotic damage in systemic rheumatic diseases: two faces of the same coin

1 reference

https://api.crossref.org/works/10.1007%2FS11883-015-0497-6

21 January 2018

Atherogenesis and autoimmune disease: the model of lupus

1 reference

https://api.crossref.org/works/10.1007%2FS11883-015-0497-6

21 January 2018

Autoimmune-mediated atherothrombosis

1 reference

https://api.crossref.org/works/10.1007%2FS11883-015-0497-6

21 January 2018

Atherosclerosis in autoimmune rheumatic diseases-mechanisms and clinical findings

1 reference

https://api.crossref.org/works/10.1007%2FS11883-015-0497-6

21 January 2018

Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1007%2FS11883-015-0497-6

21 January 2018

Premature coronary-artery atherosclerosis in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1007%2FS11883-015-0497-6

21 January 2018

Poor 1-year outcomes after percutaneous coronary interventions in systemic lupus erythematosus: report from the National Heart, Lung, and Blood Institute Dynamic Registry

1 reference

https://api.crossref.org/works/10.1007%2FS11883-015-0497-6

21 January 2018

Poor outcomes after acute myocardial infarction in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1007%2FS11883-015-0497-6

21 January 2018

Outcomes of hospitalizations for myocardial infarctions and cerebrovascular accidents in patients with systemic lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1007%2FS11883-015-0497-6

21 January 2018

Atherosclerosis and antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS11883-015-0497-6

21 January 2018

Systemic antiphospholipid syndrome and atherosclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS11883-015-0497-6

21 January 2018

Antiphospholipid antibodies as non-traditional risk factors in atherosclerosis based cardiovascular diseases without overt autoimmunity. A critical updated review

1 reference

https://api.crossref.org/works/10.1007%2FS11883-015-0497-6

21 January 2018

Cutting-edge issues in coronary disease and the primary antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS11883-015-0497-6

21 January 2018

The risk of cardiovascular disease in systemic sclerosis: a population-based cohort study

1 reference

https://api.crossref.org/works/10.1007%2FS11883-015-0497-6

21 January 2018

Effect of rheumatoid arthritis or systemic lupus erythematosus on the risk of first-time acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1007%2FS11883-015-0497-6

21 January 2018

Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1007%2FS11883-015-0497-6

21 January 2018

Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study.

1 reference

https://api.crossref.org/works/10.1007%2FS11883-015-0497-6

21 January 2018

No increased occurrence of ischemic heart disease prior to the onset of rheumatoid arthritis: results from two Swedish population-based rheumatoid arthritis cohorts.

1 reference

https://api.crossref.org/works/10.1007%2FS11883-015-0497-6

21 January 2018

Declines in mortality from acute myocardial infarction in successive incidence and birth cohorts of patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1007%2FS11883-015-0497-6

21 January 2018

The widening mortality gap between rheumatoid arthritis patients and the general population

1 reference

https://api.crossref.org/works/10.1007%2FS11883-015-0497-6

21 January 2018

Rheumatoid arthritis patients receive less frequent acute reperfusion and secondary prevention therapy after myocardial infarction compared with the general population

1 reference

https://api.crossref.org/works/10.1007%2FS11883-015-0497-6

21 January 2018

Outcomes in patients with rheumatoid arthritis and myocardial infarction.

1 reference

https://api.crossref.org/works/10.1007%2FS11883-015-0497-6

21 January 2018

Mortality after coronary artery revascularization of patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1007%2FS11883-015-0497-6

21 January 2018

Longterm outcomes and treatment after myocardial infarction in patients with rheumatoid arthritis.

1 reference

https://api.crossref.org/works/10.1007%2FS11883-015-0497-6

21 January 2018

Environmental influences on risk for rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1007%2FS11883-015-0497-6

21 January 2018

Traditional cardiovascular risk factors in rheumatoid arthritis: a meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS11883-015-0497-6

21 January 2018

Early atherosclerosis in rheumatoid arthritis: effects of smoking on thickness of the carotid artery intima media

1 reference

https://api.crossref.org/works/10.1007%2FS11883-015-0497-6

21 January 2018

Do cardiovascular risk factors confer the same risk for cardiovascular outcomes in rheumatoid arthritis patients as in non-rheumatoid arthritis patients?

1 reference

https://api.crossref.org/works/10.1007%2FS11883-015-0497-6

21 January 2018

Risk factors for coronary heart disease in women with systemic lupus erythematosus: the Toronto Risk Factor Study

1 reference

https://api.crossref.org/works/10.1007%2FS11883-015-0497-6

21 January 2018

Accumulation of coronary artery disease risk factors over three years: data from an international inception cohort

1 reference

https://api.crossref.org/works/10.1007%2FS11883-015-0497-6

21 January 2018

Atherosclerotic vascular events in a multinational inception cohort of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1007%2FS11883-015-0497-6

21 January 2018

Intensive lipid lowering in patients with rheumatoid arthritis and previous myocardial infarction: an explorative analysis from the incremental decrease in endpoints through aggressive lipid lowering (IDEAL) trial.

1 reference

https://api.crossref.org/works/10.1007%2FS11883-015-0497-6

21 January 2018

Lipid and lipoprotein levels and trend in rheumatoid arthritis compared to the general population

1 reference

https://api.crossref.org/works/10.1007%2FS11883-015-0497-6

21 January 2018

Lipids, myocardial infarction and ischaemic stroke in patients with rheumatoid arthritis in the Apolipoprotein-related Mortality RISk (AMORIS) Study

1 reference

https://api.crossref.org/works/10.1007%2FS11883-015-0497-6

21 January 2018

Total cholesterol and LDL levels decrease before rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1007%2FS11883-015-0497-6

21 January 2018

The pathogenesis of atherosclerosis in autoimmune rheumatic diseases: roles of inflammation and dyslipidemia

1 reference

https://api.crossref.org/works/10.1007%2FS11883-015-0497-6

21 January 2018

Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease

1 reference

https://api.crossref.org/works/10.1007%2FS11883-015-0497-6

21 January 2018

Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study

1 reference

https://api.crossref.org/works/10.1007%2FS11883-015-0497-6

21 January 2018

Insulin resistance and impaired beta cell function in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1007%2FS11883-015-0497-6

21 January 2018

Cardiovascular risk in rheumatoid arthritis versus osteoarthritis: acute phase response related decreased insulin sensitivity and high-density lipoprotein cholesterol as well as clustering of metabolic syndrome features in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1007%2FS11883-015-0497-6

21 January 2018

Inflammation-associated insulin resistance: differential effects in rheumatoid arthritis and systemic lupus erythematosus define potential mechanisms

1 reference

https://api.crossref.org/works/10.1007%2FS11883-015-0497-6

21 January 2018

Increased prevalence of metabolic syndrome associated with rheumatoid arthritis in patients without clinical cardiovascular disease

1 reference

https://api.crossref.org/works/10.1007%2FS11883-015-0497-6

21 January 2018

Years of life lost due to obesity

1 reference

https://api.crossref.org/works/10.1007%2FS11883-015-0497-6

21 January 2018

Blood transfusion, smoking, and obesity as risk factors for the development of rheumatoid arthritis: results from a primary care-based incident case-control study in Norfolk, England.

1 reference

https://api.crossref.org/works/10.1007%2FS11883-015-0497-6

21 January 2018

Usefulness of risk scores to estimate the risk of cardiovascular disease in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1007%2FS11883-015-0497-6

21 January 2018

Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1007%2FS11883-015-0497-6

21 January 2018

High ten-year risk of cardiovascular disease in newly diagnosed rheumatoid arthritis patients: a population-based cohort study

1 reference

https://api.crossref.org/works/10.1007%2FS11883-015-0497-6

21 January 2018

'Not only...but also': factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1007%2FS11883-015-0497-6

21 January 2018

Cardiovascular risk factors in women with and without rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1007%2FS11883-015-0497-6

21 January 2018

Accelerated atherosclerosis in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1007%2FS11883-015-0497-6

21 January 2018

Early functional disability predicts both all-cause and cardiovascular mortality in people with inflammatory polyarthritis: results from the Norfolk Arthritis Register.

1 reference

https://api.crossref.org/works/10.1007%2FS11883-015-0497-6

21 January 2018

Autoantibodies and the risk of cardiovascular events

1 reference

https://api.crossref.org/works/10.1007%2FS11883-015-0497-6

21 January 2018

Association between anti-cyclic citrullinated peptide antibodies and ischemic heart disease in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1007%2FS11883-015-0497-6

21 January 2018

Risk factors for clinical coronary heart disease in systemic lupus erythematosus: the lupus and atherosclerosis evaluation of risk (LASER) study

1 reference

https://api.crossref.org/works/10.1007%2FS11883-015-0497-6

21 January 2018

Proinflammatory high-density lipoprotein as a biomarker for atherosclerosis in patients with systemic lupus erythematosus and rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1007%2FS11883-015-0497-6

21 January 2018

Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS11883-015-0497-6

21 January 2018

Immunosuppressive medications and hospitalization for cardiovascular events in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1007%2FS11883-015-0497-6

21 January 2018

Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study

1 reference

https://api.crossref.org/works/10.1007%2FS11883-015-0497-6

21 January 2018

The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review

1 reference

https://api.crossref.org/works/10.1007%2FS11883-015-0497-6

21 January 2018

Disease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study

1 reference

https://api.crossref.org/works/10.1007%2FS11883-015-0497-6

21 January 2018

Effect of hydroxychloroquine on the survival of patients with systemic lupus erythematosus: data from LUMINA, a multiethnic US cohort (LUMINA L)

1 reference

https://api.crossref.org/works/10.1007%2FS11883-015-0497-6

21 January 2018

Increased case fatality rates following a first acute cardiovascular event in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1007%2FS11883-015-0497-6

21 January 2018

Baseline levels of c-reactive protein and prediction of death from cardiovascular disease in patients with inflammatory polyarthritis : A ten-year followup study of a primary care-based inception cohort

1 reference

https://api.crossref.org/works/10.1007%2FS11883-015-0497-6

21 January 2018

Anti-cardiolipin antibodies and risk of myocardial infarction in a prospective cohort of middle-aged men

1 reference

https://pubmed.ncbi.nlm.nih.gov/25721102

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk factors for coronary artery disease in patients with systemic lupus erythematosus

1 reference

https://pubmed.ncbi.nlm.nih.gov/25721102

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Atherosclerotic vascular events in a single large lupus cohort: prevalence and risk factors.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25721102

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Atherosclerosis and the antiphospholipid syndrome: a link unravelled?

1 reference

https://pubmed.ncbi.nlm.nih.gov/25721102

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection of activated T lymphocytes in the human atherosclerotic plaque

1 reference

https://pubmed.ncbi.nlm.nih.gov/25721102

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vascular events in hypertensive patients with systemic lupus erythematosus

1 reference

https://pubmed.ncbi.nlm.nih.gov/25721102

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Up-regulation of cytokines and chemokines predates the onset of rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/25721102

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic importance of low body mass index in relation to cardiovascular mortality in rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/25721102

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Associations of obesity with modifiable risk factors for the development of cardiovascular disease in patients with rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/25721102

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Does rheumatoid arthritis equal diabetes mellitus as an independent risk factor for cardiovascular disease? A prospective study

1 reference

https://pubmed.ncbi.nlm.nih.gov/25721102

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25721102

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Smoking, obesity, alcohol consumption, and the risk of rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/25721102

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The metabolic syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/25721102

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Paradoxical effect of body mass index on survival in rheumatoid arthritis: role of comorbidity and systemic inflammation

1 reference

https://pubmed.ncbi.nlm.nih.gov/25721102

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosus

1 reference

https://pubmed.ncbi.nlm.nih.gov/25721102

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Smoking and risk of rheumatoid arthritis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25721102

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/25721102

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Crossreaction between antibodies to oxidised low-density lipoprotein and to cardiolipin in systemic lupus erythematosus

1 reference

https://pubmed.ncbi.nlm.nih.gov/25721102

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differences in atherosclerotic coronary heart disease between subjects with and without rheumatoid arthritis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25721102

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevalence of the metabolic syndrome is increased in rheumatoid arthritis and is associated with coronary atherosclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/25721102

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cardiovascular death in rheumatoid arthritis: a population-based study

1 reference

https://pubmed.ncbi.nlm.nih.gov/25721102

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Brief report: accelerated aging influences cardiovascular disease risk in rheumatoid arthritis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25721102

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Survival in rheumatoid arthritis: a population-based analysis of trends over 40 years

1 reference

https://pubmed.ncbi.nlm.nih.gov/25721102

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Arterial foam cells with distinctive immunomorphologic and histochemical features of macrophages

1 reference

https://pubmed.ncbi.nlm.nih.gov/25721102

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevalence and associations of hypertension and its control in patients with rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/25721102

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Length of life and cause of death in rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/25721102

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11883-015-0497-6

1 reference

Europe PubMed Central

2 September 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

2 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38365624&oldid=1756206990"